CATALOGO DEI PRODOTTI DELLA RICERCA

CORBO, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.476
NA - Nord America 7.473
AS - Asia 5.421
SA - Sud America 773
Continente sconosciuto - Info sul continente non disponibili 344
AF - Africa 172
OC - Oceania 45
Totale 21.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.237
RU - Federazione Russa 2.826
SG - Singapore 2.064
CN - Cina 1.520
GB - Regno Unito 1.310
IT - Italia 1.284
BR - Brasile 600
HK - Hong Kong 563
VN - Vietnam 480
DE - Germania 407
IE - Irlanda 305
SE - Svezia 299
FR - Francia 295
FI - Finlandia 208
KR - Corea 154
NL - Olanda 153
BD - Bangladesh 152
CA - Canada 124
IN - India 106
JP - Giappone 68
UA - Ucraina 68
AT - Austria 67
ES - Italia 60
AR - Argentina 57
MX - Messico 48
TR - Turchia 47
ID - Indonesia 44
AU - Australia 40
PL - Polonia 40
NG - Nigeria 36
IQ - Iraq 35
ZA - Sudafrica 31
BE - Belgio 30
EC - Ecuador 29
CO - Colombia 27
TG - Togo 24
UZ - Uzbekistan 22
BJ - Benin 18
JO - Giordania 18
PK - Pakistan 18
VE - Venezuela 18
MA - Marocco 17
CZ - Repubblica Ceca 16
LT - Lituania 16
CH - Svizzera 15
IR - Iran 15
SA - Arabia Saudita 15
JM - Giamaica 14
PY - Paraguay 14
PH - Filippine 13
CR - Costa Rica 12
MY - Malesia 12
CL - Cile 11
KE - Kenya 10
TN - Tunisia 10
AZ - Azerbaigian 9
PT - Portogallo 9
AL - Albania 8
BG - Bulgaria 8
IL - Israele 8
EG - Egitto 7
HN - Honduras 7
NP - Nepal 7
GR - Grecia 6
GT - Guatemala 6
NI - Nicaragua 6
PE - Perù 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
TW - Taiwan 5
ET - Etiopia 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
PA - Panama 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BN - Brunei Darussalam 3
DK - Danimarca 3
DZ - Algeria 3
EE - Estonia 3
MD - Moldavia 3
OM - Oman 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CI - Costa d'Avorio 2
CY - Cipro 2
GE - Georgia 2
GY - Guiana 2
Totale 21.329
Salva come PNG Salva come JPEG
Città #
Southend 1.100
Singapore 1.057
Moscow 959
Ashburn 945
San Jose 724
Chandler 706
Dallas 618
Hong Kong 542
Verona 528
Council Bluffs 346
Beijing 339
Dublin 289
Jacksonville 238
New York 231
The Dalles 224
Ann Arbor 220
Woodbridge 207
Los Angeles 161
Ho Chi Minh City 134
Munich 130
Hanoi 118
Jinan 107
Lawrence 97
Princeton 97
Houston 93
Milan 91
Wilmington 91
Redmond 83
Santa Clara 75
Shenyang 69
São Paulo 68
Nanjing 67
Helsinki 65
Orem 59
Redondo Beach 59
Buffalo 57
Tokyo 57
London 52
Turku 50
Hebei 49
Tianjin 47
Columbus 46
Amsterdam 42
Sindelfingen 41
Vienna 40
Zhengzhou 40
Haikou 38
Seattle 36
Warsaw 36
Abuja 35
Brooklyn 35
Changsha 35
Denver 35
Chennai 34
Dearborn 34
Frankfurt am Main 34
Montreal 34
Ningbo 34
Rome 34
Toronto 32
Hangzhou 31
Nuremberg 31
Brussels 30
Dong Ket 28
Lappeenranta 27
Madrid 27
Stockholm 27
Bologna 26
Chicago 26
Guangzhou 25
San Francisco 25
Jakarta 24
Lomé 24
Phoenix 24
Taiyuan 24
Poplar 22
Redwood City 22
Boardman 21
Haiphong 21
Manchester 21
Johannesburg 20
Taizhou 20
Ankara 19
Atlanta 19
Barnet 19
Mexico City 19
Nanchang 19
Washington 19
Boston 18
Cotonou 18
Falkenstein 18
Sydney 18
Tashkent 18
Jiaxing 17
Brescia 16
Norwalk 16
Paris 16
Shanghai 16
Amman 15
Da Nang 15
Totale 12.805
Salva come PNG Salva come JPEG
Nome #
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 305
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 289
Whole-genome landscape of pancreatic neuroendocrine tumours 286
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 284
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 269
Genomic analyses identify molecular subtypes of pancreatic cancer 258
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 256
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 249
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 234
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 221
RON is not a prognostic marker for resectable pancreatic cancer 215
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 214
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 214
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 208
Sex differences in oncogenic mutational processes 207
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
Complete neural stem cell (nsc) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism 202
A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer 200
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 200
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 197
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 196
Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation 196
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 196
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 195
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 195
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 194
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 194
Pancreatic cancer genomics 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 192
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 190
Author Correction: The landscape of viral associations in human cancers 190
Comparative Lesions Analysis Through a Targeted Sequencing Approach 190
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 190
Lost in translation: returning germline genetic results in genome-scale cancer research 189
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 187
Molecular biology of neuroendocrine tumors 186
Divergent mutational processes distinguish hypoxic and normoxic tumours 185
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 184
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract. 182
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 182
Fhit down-regulation is an early event in pancreatic carcinogenesis 179
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 179
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 179
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 178
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 176
Hypermutation In Pancreatic Cancer 175
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance 174
Molecular Pathology of Pancreatic Cancer: from bench-to-bedside translation. 173
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 173
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 172
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 172
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 172
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 171
Mutational analysis of cancer candidate genes in different pancreatic cancer types 169
Loss of FGFR4 promotes the malignant phenotype of PDAC 168
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 168
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 166
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 166
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 165
Local ablation disrupts immune evasion in pancreatic cancer 164
Exosomal miRNA signatures of pancreatic lesions 164
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 161
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 159
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 159
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 159
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 158
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 158
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 158
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer 156
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 156
Molecular alterations in basal cell carcinoma subtypes 156
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 153
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 153
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 152
Long-term organoid culture of a small intestinal neuroendocrine tumor 152
Muscle derangement and alteration of the nutritional machinery in NSCLC 152
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 151
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 150
Generation of Pancreatic Organoid-Derived Isografts 150
Whole genomes redefine the mutational landscape of pancreatic cancer 147
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 147
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 145
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 144
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 144
Author Correction: Pan-cancer analysis of whole genomes 144
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 142
Profiling mTOR pathway in neuroendocrine tumors. 142
Combined burden and functional impact tests for cancer driver discovery using DriverPower 140
Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma 138
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care 136
Mutational profile of GNAQQ209 in human tumors 136
Profiling mTOR pathway in neuroendocrine tumors 136
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 135
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer 135
Current role of non-coding RNAs in the clinical setting 135
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 134
Preclinical Modelling of PDA: Is Organoid the New Black? 134
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 132
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 132
Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward 131
Totale 17.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.259
article - articoli 68.809
book - libri 0
conference - conferenze 2.542
curatela - curatele 0
other - altro 2.248
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.660
Totale 150.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022884 0 311 33 50 39 37 29 58 35 16 76 200
2022/20231.889 113 222 150 328 160 453 23 115 230 19 41 35
2023/20241.225 43 76 78 106 139 211 61 144 29 85 186 67
2024/20253.647 179 161 177 529 201 179 245 216 524 251 373 612
2025/202610.120 691 491 705 1.582 2.524 618 906 530 828 665 248 332
2026/2027508 166 342 0 0 0 0 0 0 0 0 0 0
Totale 21.704